chr3-55992161-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015576.3(ERC2):āc.2151C>Gā(p.Asp717Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 152,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015576.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERC2 | NM_015576.3 | c.2151C>G | p.Asp717Glu | missense_variant | 11/18 | ENST00000288221.11 | NP_056391.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERC2 | ENST00000288221.11 | c.2151C>G | p.Asp717Glu | missense_variant | 11/18 | 1 | NM_015576.3 | ENSP00000288221 | P1 | |
ERC2 | ENST00000460849.5 | c.2151C>G | p.Asp717Glu | missense_variant, NMD_transcript_variant | 11/19 | 1 | ENSP00000417445 | |||
ERC2 | ENST00000492584.3 | c.2187C>G | p.Asp729Glu | missense_variant | 12/18 | 5 | ENSP00000417280 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249150Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135160
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2024 | The c.2151C>G (p.D717E) alteration is located in exon 11 (coding exon 10) of the ERC2 gene. This alteration results from a C to G substitution at nucleotide position 2151, causing the aspartic acid (D) at amino acid position 717 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at